Patents by Inventor Rudolf Stefan Widmann

Rudolf Stefan Widmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR THE PARENTERAL ADMINISTRATION OF ULTRASHORT-EFFECTIVE BETA-ADRENORECEPTOR ANTAGONISTS
    Publication number: 20230277674
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Application
    Filed: December 5, 2022
    Publication date: September 7, 2023
    Applicant: AOP ORPHAN PHARMACEUTICALS AG
    Inventor: Rudolf Stefan WIDMANN
  • Pharmaceutical composition for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists
    Patent number: 11517624
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: December 6, 2022
    Assignee: AOP ORPHAN PHARMACEUTICALS GMBH
    Inventor: Rudolf Stefan Widmann
  • PHARMACEUTICAL COMPOSITION FOR THE PARENTERAL ADMINISTRATION OF ULTRASHORT-EFFECTIVE BETA-ADRENORECEPTOR ANTAGONISTS
    Publication number: 20200323988
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Application
    Filed: April 28, 2020
    Publication date: October 15, 2020
    Applicant: AOP ORPHAN PHARMACEUTICALS AG
    Inventor: Rudolf Stefan WIDMANN
  • Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists
    Patent number: 10660964
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: May 26, 2020
    Assignee: AOP Orphan Pharmaceuticals AG
    Inventor: Rudolf Stefan Widmann
  • PHARMACEUTICAL COMPOSITION FOR THE PARENTERAL ADMINISTRATION OF ULTRASHORT-EFFECTIVE BETA-ADRENORECEPTOR ANTAGONISTS
    Publication number: 20190046646
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 14, 2019
    Applicant: AOP ORPHAN PHARMACEUTICALS AG
    Inventor: Rudolf Stefan WIDMANN
  • Pharmaceutical Composition for the Parenteral Administration of Ultrashort-Effective Beta-Adrenoreceptor Antagonists
    Publication number: 20160361422
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Application
    Filed: August 26, 2016
    Publication date: December 15, 2016
    Inventor: Rudolf Stefan Widmann
  • Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists
    Publication number: 20100311738
    Abstract: The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ?-adrenoreceptor antagonists, comprising a) an ultrashort-effective ?-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
    Type: Application
    Filed: December 22, 2008
    Publication date: December 9, 2010
    Applicant: AOP ORPHAN PHARMACEUTICALS AG
    Inventor: Rudolf Stefan Widmann